Published in J Clin Psychiatry on March 01, 2007
Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol (2009) 11.59
The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull (2009) 4.69
Transcranial magnetic stimulation of Wernicke's and Right homologous sites to curtail "voices": a randomized trial. Biol Psychiatry (2013) 1.57
The functional neuroanatomy of symptom dimensions in schizophrenia: a qualitative and quantitative review of a persistent question. Neurosci Biobehav Rev (2009) 1.30
Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS). Neuropsychopharmacology (2010) 1.25
Transcranial magnetic stimulation: a neuroscientific probe of cortical function in schizophrenia. Biol Psychiatry (2011) 1.22
Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia. Schizophr Res (2009) 1.19
The cognitive neuropsychology of auditory hallucinations: a parallel auditory pathways framework. Schizophr Bull (2008) 1.01
Use of repetitive transcranial magnetic stimulation for treatment in psychiatry. Clin Psychopharmacol Neurosci (2013) 1.01
The treatment of hallucinations in schizophrenia spectrum disorders. Schizophr Bull (2012) 1.00
Brain stimulation in psychiatry and its effects on cognition. Nat Rev Neurol (2010) 0.98
Cerebral blood flow identifies responders to transcranial magnetic stimulation in auditory verbal hallucinations. Transl Psychiatry (2012) 0.96
Long-term potentiation and long-term depression: a clinical perspective. Clinics (Sao Paulo) (2011) 0.95
Repeated measurements of cerebral blood flow in the left superior temporal gyrus reveal tonic hyperactivity in patients with auditory verbal hallucinations: a possible trait marker. Front Hum Neurosci (2013) 0.91
Pharmacotherapy for treatment-resistant schizophrenia. Neuropsychiatr Dis Treat (2011) 0.89
Individualized rTMS neuronavigated according to regional brain metabolism ((18)FGD PET) has better treatment effects on auditory hallucinations than standard positioning of rTMS: a double-blind, sham-controlled study. Eur Arch Psychiatry Clin Neurosci (2012) 0.87
Repetitive TMS combined with exposure therapy for PTSD: a preliminary study. J Anxiety Disord (2008) 0.84
Taking back the brain: could neurofeedback training be effective for relieving distressing auditory verbal hallucinations in patients with schizophrenia? Schizophr Bull (2012) 0.84
Current and emergent treatments for symptoms and neurocognitive impairment in schizophrenia. Curr Treat Options Psychiatry (2015) 0.83
Auditory verbal hallucinations: imaging, analysis, and intervention. Eur Arch Psychiatry Clin Neurosci (2012) 0.82
rTMS strategies for the study and treatment of schizophrenia: a review. Int J Neuropsychopharmacol (2008) 0.82
Noninvasive brain stimulation for the treatment of auditory verbal hallucinations in schizophrenia: methods, effects and challenges. Front Syst Neurosci (2015) 0.79
Short and long term effects of left and bilateral repetitive transcranial magnetic stimulation in schizophrenia patients with auditory verbal hallucinations: a randomized controlled trial. PLoS One (2014) 0.79
Efficacy of Transcranial Magnetic Stimulation (TMS) in the Treatment of Schizophrenia: A Review of the Literature to Date. Innov Clin Neurosci (2015) 0.78
Mechanisms Underlying Auditory Hallucinations-Understanding Perception without Stimulus. Brain Sci (2013) 0.78
Placebo Response in Repetitive Transcranial Magnetic Stimulation Trials of Treatment of Auditory Hallucinations in Schizophrenia: A Meta-Analysis. Schizophr Bull (2015) 0.78
Impact of Repetitive Transcranial Magnetic Stimulation (rTMS) on Brain Functional Marker of Auditory Hallucinations in Schizophrenia Patients. Brain Sci (2013) 0.77
Efficacy and safety of bilateral continuous theta burst stimulation (cTBS) for the treatment of chronic tinnitus: design of a three-armed randomized controlled trial. Trials (2009) 0.76
Solving the orientation specific constraints in transcranial magnetic stimulation by rotating fields. PLoS One (2014) 0.76
Repetitive transcranial magnetic stimulation for clinical applications in neurological and psychiatric disorders: an overview. Eurasian J Med (2013) 0.76
Transcranial magnetic stimulation for the treatment of pharmacoresistant nondelusional auditory verbal hallucinations in dementia. Case Rep Psychiatry (2013) 0.76
Repetitive transcranial magnetic stimulation for hallucination in schizophrenia spectrum disorders: A meta-analysis. Neural Regen Res (2013) 0.76
Clinical handling and understanding of schizophrenia should be based on pathophysiological findings and theories. World Psychiatry (2011) 0.75
Review: slow repetitive transcranial magnetic stimulation reduces auditory hallucinations in people with schizophrenia. Evid Based Ment Health (2007) 0.75
Promoting social plasticity in developmental disorders with non-invasive brain stimulation techniques. Front Neurosci (2015) 0.75
On the neurobiology of hallucinations. J Psychiatry Neurosci (2009) 0.75
A Review of Impaired Neuroplasticity in Schizophrenia Investigated with Non-invasive Brain Stimulation. Front Psychiatry (2016) 0.75
rTMS in the management of auditory hallucinations in patients with schizophrenia. Shanghai Arch Psychiatry (2013) 0.75
Use of transcranial direct current stimulation for the treatment of auditory hallucinations of schizophrenia - a systematic review. Neuropsychiatr Dis Treat (2017) 0.75
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Efficiency of functional brain networks and intellectual performance. J Neurosci (2009) 4.25
Functionally linked resting-state networks reflect the underlying structural connectivity architecture of the human brain. Hum Brain Mapp (2009) 4.22
The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry (2006) 3.86
Aberrant frontal and temporal complex network structure in schizophrenia: a graph theoretical analysis. J Neurosci (2010) 3.80
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
The relationship of DNA methylation with age, gender and genotype in twins and healthy controls. PLoS One (2009) 3.41
Genetic influences on human brain structure: a review of brain imaging studies in twins. Hum Brain Mapp (2007) 3.15
Aging effects on DNA methylation modules in human brain and blood tissue. Genome Biol (2012) 3.05
Affective state and decision-making in the Ultimatum Game. Exp Brain Res (2006) 2.91
Do women really have more bilateral language representation than men? A meta-analysis of functional imaging studies. Brain (2004) 2.86
Brain volumes in relatives of patients with schizophrenia: a meta-analysis. Arch Gen Psychiatry (2007) 2.70
Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis. Schizophr Res (2004) 2.61
Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum Brain Mapp (2009) 2.55
Cannabis use and age at onset of schizophrenia. Am J Psychiatry (2004) 2.49
Abnormal rich club organization and functional brain dynamics in schizophrenia. JAMA Psychiatry (2013) 2.47
High-cost, high-capacity backbone for global brain communication. Proc Natl Acad Sci U S A (2012) 2.42
Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry (2003) 2.41
Auditory verbal hallucinations predominantly activate the right inferior frontal area. Brain (2008) 2.35
Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol Psychiatry (2008) 2.28
The association between brain volume and intelligence is of genetic origin. Nat Neurosci (2002) 2.21
Lateralization of amygdala activation: a systematic review of functional neuroimaging studies. Brain Res Brain Res Rev (2004) 2.05
Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study. Neuropsychopharmacology (2007) 1.98
Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. Schizophr Bull (2012) 1.97
Genetic contributions to human brain morphology and intelligence. J Neurosci (2006) 1.97
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry (2010) 1.90
Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology (2008) 1.88
Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis. J Clin Psychiatry (2011) 1.83
What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophr Bull (2008) 1.80
Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies. Schizophr Bull (2011) 1.78
Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). Am J Psychiatry (2009) 1.71
Genetic analysis of DNA methylation and gene expression levels in whole blood of healthy human subjects. BMC Genomics (2012) 1.70
Reduced proactive inhibition in schizophrenia is related to corticostriatal dysfunction and poor working memory. Biol Psychiatry (2011) 1.70
Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia? Prog Neurobiol (2005) 1.69
Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol. Br J Psychiatry (2005) 1.68
Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch Gen Psychiatry (2002) 1.68
Diagnostic stability in a Dutch psychosis incidence cohort. Br J Psychiatry (2004) 1.67
Impaired recognition and expression of emotional prosody in schizophrenia: review and meta-analysis. Schizophr Res (2007) 1.60
Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol Psychiatry (2007) 1.58
Deactivation of the parahippocampal gyrus preceding auditory hallucinations in schizophrenia. Am J Psychiatry (2010) 1.55
Magnetic resonance imaging of boys with attention-deficit/hyperactivity disorder and their unaffected siblings. J Am Acad Child Adolesc Psychiatry (2004) 1.53
Repetitive transcranial magnetic stimulation over the right dorsolateral prefrontal cortex affects strategic decision-making. Neuroreport (2005) 1.52
Effects of δ9-tetrahydrocannabinol on human working memory function. Biol Psychiatry (2012) 1.51
Function of striatum beyond inhibition and execution of motor responses. Hum Brain Mapp (2005) 1.51
Sex steroids and brain structure in pubertal boys and girls. Psychoneuroendocrinology (2008) 1.50
The same or different? A phenomenological comparison of auditory verbal hallucinations in healthy and psychotic individuals. J Clin Psychiatry (2011) 1.49
Human brain changes across the life span: a review of 56 longitudinal magnetic resonance imaging studies. Hum Brain Mapp (2011) 1.48
A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes. PLoS One (2012) 1.45
Heritability of regional and global brain structure at the onset of puberty: a magnetic resonance imaging study in 9-year-old twin pairs. Hum Brain Mapp (2009) 1.43
Social behavior and autism traits in a sex chromosomal disorder: Klinefelter (47XXY) syndrome. J Autism Dev Disord (2008) 1.39
Auditory hallucinations elicit similar brain activation in psychotic and nonpsychotic individuals. Schizophr Bull (2011) 1.39
The characteristic features of auditory verbal hallucinations in clinical and nonclinical groups: state-of-the-art overview and future directions. Schizophr Bull (2012) 1.34
Can low-frequency repetitive transcranial magnetic stimulation really relieve medication-resistant auditory verbal hallucinations? Negative results from a large randomized controlled trial. Biol Psychiatry (2010) 1.34
Genetic correlations between brain volumes and the WAIS-III dimensions of verbal comprehension, working memory, perceptual organization, and processing speed. Twin Res (2003) 1.31
Reliability of brain volumes from multicenter MRI acquisition: a calibration study. Hum Brain Mapp (2004) 1.31
Cardiorespiratory effects on default-mode network activity as measured with fMRI. Hum Brain Mapp (2009) 1.30
Expectations and violations: delineating the neural network of proactive inhibitory control. Hum Brain Mapp (2012) 1.28
Increased gray-matter volume in medication-naive high-functioning children with autism spectrum disorder. Psychol Med (2005) 1.27
Volume changes in gray matter in patients with schizophrenia. Am J Psychiatry (2002) 1.27
Functional diffusion tensor imaging: measuring task-related fractional anisotropy changes in the human brain along white matter tracts. PLoS One (2008) 1.26
Heritability of changes in brain volume over time in twin pairs discordant for schizophrenia. Arch Gen Psychiatry (2008) 1.25
Chronic effects of cannabis use on the human reward system: an fMRI study. Eur Neuropsychopharmacol (2010) 1.24
Heritability of DTI and MTR in nine-year-old children. Neuroimage (2010) 1.22
Influence of genes and environment on brain volumes in twin pairs concordant and discordant for bipolar disorder. Arch Gen Psychiatry (2009) 1.22
Changes in cortical thickness during the course of illness in schizophrenia. Arch Gen Psychiatry (2011) 1.21
Tract-based analysis of magnetization transfer ratio and diffusion tensor imaging of the frontal and frontotemporal connections in schizophrenia. Schizophr Bull (2008) 1.21
Cognitive basis of hallucinations in schizophrenia: role of top-down information processing. Schizophr Res (2003) 1.20
Underestimated effect sizes in GWAS: fundamental limitations of single SNP analysis for dichotomous phenotypes. PLoS One (2011) 1.19
Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update. Schizophr Bull (2013) 1.18
Prevalence of 22q11.2 deletions in 311 Dutch patients with schizophrenia. Schizophr Res (2007) 1.16
Brain volumes as predictor of outcome in recent-onset schizophrenia: a multi-center MRI study. Schizophr Res (2003) 1.15
Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity. Neuroimage (2004) 1.14
Expression QTL analysis of top loci from GWAS meta-analysis highlights additional schizophrenia candidate genes. Eur J Hum Genet (2012) 1.14
Can structural MRI aid in clinical classification? A machine learning study in two independent samples of patients with schizophrenia, bipolar disorder and healthy subjects. Neuroimage (2013) 1.14
Neuronal substrate of the saccadic inhibition deficit in schizophrenia investigated with 3-dimensional event-related functional magnetic resonance imaging. Arch Gen Psychiatry (2002) 1.13
Effects of gestational age and birth weight on brain volumes in healthy 9 year-old children. J Pediatr (2010) 1.12
The effects of physical exercise in schizophrenia and affective disorders. Eur Arch Psychiatry Clin Neurosci (2013) 1.11
Sex differences in handedness, asymmetry of the planum temporale and functional language lateralization. Brain Res (2008) 1.11
Psychiatric morbidity and X-chromosomal origin in a Klinefelter sample. Schizophr Res (2007) 1.10
The European First Episode Schizophrenia Trial (EUFEST): rationale and design of the trial. Schizophr Res (2005) 1.09
Emotional processing in a non-clinical psychosis-prone sample. Schizophr Res (2004) 1.09
Cannabis with high cannabidiol content is associated with fewer psychotic experiences. Schizophr Res (2011) 1.09
Dopaminergic function in the psychosis spectrum: an [18F]-DOPA imaging study in healthy individuals with auditory hallucinations. Schizophr Bull (2012) 1.09
Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia. J Clin Psychopharmacol (2002) 1.09
Within-subject variation in BOLD-fMRI signal changes across repeated measurements: quantification and implications for sample size. Neuroimage (2008) 1.08
Impaired cerebellar functional connectivity in schizophrenia patients and their healthy siblings. Front Psychiatry (2011) 1.08
X Chromosomal effects on social cognitive processing and emotion regulation: A study with Klinefelter men (47,XXY). Schizophr Res (2006) 1.08
Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder? Biol Psychiatry (2006) 1.07
Striatal dysfunction in schizophrenia and unaffected relatives. Biol Psychiatry (2006) 1.07
Brain plasticity and intellectual ability are influenced by shared genes. J Neurosci (2010) 1.06
Gray and white matter volume abnormalities in monozygotic and same-gender dizygotic twins discordant for schizophrenia. Biol Psychiatry (2004) 1.06
Classification of schizophrenia patients and healthy controls from structural MRI scans in two large independent samples. Neuroimage (2012) 1.05
Migration and schizophrenia. Curr Opin Psychiatry (2007) 1.05
Transcranial magnetic stimulation and functional MRI reveal cortical and subcortical interactions during stop-signal response inhibition. J Cogn Neurosci (2012) 1.05
A controlled study of brain structure in monozygotic twins concordant and discordant for schizophrenia. Biol Psychiatry (2004) 1.05
Heritability of subcortical brain measures: a perspective for future genome-wide association studies. Neuroimage (2013) 1.05